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SERPINB3/B4 Contributes to Early Inflammation and
Barrier Dysfunction in an Experimental Murine Model
of Atopic Dermatitis
Umasundari Sivaprasad1, Kayla G. Kinker1, Mark B. Ericksen1, Mark Lindsey1, Aaron M. Gibson1,
Stacey A. Bass1, Nicolas S. Hershey1, Jingyuan Deng2, Mario Medvedovic2 and Gurjit K. Khurana Hershey1
Serine proteases are critical for epidermal barrier homeostasis, and their aberrant expression and/or activity is
associated with chronic skin diseases. Elevated levels of the serine protease inhibitors SERPINB3 and SERPINB4
are seen in patients with atopic dermatitis and psoriasis. However, their mechanistic role in the skin is unknown.
To evaluate the contribution of Serpinb3a (mouse homolog of SERPINB3 and SERPINB4) in atopic dermatitis, we
examined the effect of topical Aspergillus fumigatus extract exposure in wild-type and Serpinb3a-null mice on
transepidermal water loss (TEWL), sensitization, and inflammation. Allergen exposure induced Serpinb3a
expression in the skin, along with increased TEWL, epidermal thickness, and skin inflammation, all of which
were attenuated in the absence of Serpinb3a. Attenuated TEWL correlated with decreased expression of the pro-
inflammatory marker S100A8. Silencing of SERPINB3/B4 in human keratinocytes decreased S100A8 expression,
supporting a role for SERPINB3/B4 in the initiation of the acute inflammatory response. RNA-seq analysis
following allergen exposure identified a network of pro-inflammatory genes induced in wild-type mice that was
absent in Serpinb3a-null mice. In conclusion, Serpinb3a deficiency attenuates barrier dysfunction and the early
inflammatory response following cutaneous allergen exposure, supporting a role for Serpinb3a (mice) and
SERPINB3/B4 (humans) early in atopic dermatitis.
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INTRODUCTION
The importance of protease function in maintaining skin
architecture and regulating responses to pathogens and aller-
gens is well established (Cork et al., 2009). Mass spectrometric
analysis identified SERPINB4 in exudates from non-healing
skin wounds but not in healing wounds (Eming et al., 2010).
Subjects with elevated SERPINB3 serum levels show greater
changes in transepidermal water loss (TEWL) in response to
oleic acid application (Katagiri et al., 2010). SERPINB3/B4
expression is increased in the skin and serum of individuals
with psoriasis (Takeda et al., 2002; Suarez-Farinas et al., 2010;
Tian et al., 2012) and atopic dermatitis (AD) (Kawashima
et al., 2000; Mitsuishi et al., 2005; Saaf et al., 2008; Broccardo
et al., 2009; Lu et al., 2009a,b). SERPINB3/B4 expression is
detected in the horny layer of skin lesions from individuals
with AD, and the level of expression correlates with serum
total IgE levels (Yamane et al., 2009). SERPINB3/B4 expression
is higher in the involved skin of individuals with AD compared
with uninvolved skin, levels correlate with disease severity
(Kawashima et al., 2000; Mitsuishi et al., 2005), and
levels return to baseline in AD patients who show improve-
ment post treatment (Kawashima et al., 2000). In vitro studies
in keratinocytes and other cell types have demonstrated that
overexpression of SERPINB3/B4 protected the cells from UV,
gamma radiation, and tumor necrosis factor (TNF) alpha–
induced cell death (Murakami et al., 2001; Hashimoto
et al., 2005; Katagiri et al., 2006), further support-
ing the key role of SERPINB3/B4 in the skin. Thus, there is
considerable evidence implicating SERPINB3/B4 in skin
inflammation. However, the role of these proteins in AD has
yet to be defined.
We utilized Serpinb3a (mouse homolog of SERPINB3/B4)-
knockout (KO) mice that we have previously described
(Sivaprasad et al., 2011) to directly examine the role of
SERPINB3/B4 in mouse models of AD following mold
exposure. We examined early and late effects of exposure to
Aspergillus fumigatus extract (ASP). Serpinb3a KO mice had
attenuated inflammatory phenotypes associated with less
TEWL compared with their wild-type (WT) counterparts.
Furthermore, SERPINB3/B4 downregulation in human kerati-
nocytes was associated with markedly attenuated expression
of S100A8, a marker of early inflammation, implicating
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SERPINB3/B4 in initiating early inflammatory events that lead
to chronic skin conditions like AD.
RESULTS
Serpinb3a is not required for the development of chronic AD
TEWL is a well-established measure of skin barrier function
(Gupta et al., 2008; Sivaprasad et al., 2010), and elevated
TEWL is a hallmark of AD in children. Following repeated
cutaneous exposure to ASP using the more chronic
conventional model (Figure 1a), WT Balb/c and Serpinb3a-
null (KO) mice exhibited no differences in barrier function as
assessed by TEWL at baseline. TEWL increased following
exposure to ASP after the second and third patches, and there
were no differences based on genotype (Figure 1b and c). Both
WT and KO mice were effectively sensitized (Figure 1d and e),
and lymph node cells cultured in the presence of ASP
produced comparable levels of IL-4 (Figure 1f) and IL-17
(Figure 1g) independent of genotype. Together, the data indicate
that the absence of Serpinb3a does not impact the develop-
ment of an AD-like response in mice following allergen
exposure over several weeks.
Serpinb3a contributes to barrier dysfunction early after allergen
exposure
In asthma, SERPINB3/B4 expression is increased during an
acute exacerbation (Guajardo et al., 2005). In AD, SERPINB3/
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Figure 1. Serpinb3a is not required for the development of chronic atopic dermatitis (AD). (a) Schematic describing our chronic AD model. Transepidermal
water loss (TEWL) measurements after the second (b) and third (c) patches. Sensitization to allergen measured by Aspergillus fumigatus extract (ASP)-specific IgG1
(d) and ASP-specific IgE (e). Production of IL-4 (f) and IL-17 (g) in supernatants of lymph node cultures of ASP-patched mice cultured with saline (SAL) or ASP for 5
days. Data shown are representative of three independent experiments (n¼ 6–8 per group).
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B4 expression is associated with disease severity and is also
higher in involved skin compared with uninvolved skin
(Kawashima et al., 2000; Mitsuishi et al., 2005). In wound
exudates, SERPINB4 levels are higher in non-healing wounds
compared with healing wounds (Eming et al., 2010). This led
us to speculate that the role of SERPINB3/B4 (or their mouse
homolog) is likely to be part of the acute response rather than
a chronic effect. To address this, we used a shorter model of
cutaneous allergen exposure (three patches, each applied for 3
days, with a 24-hour rest period after each; Figure 2a). In this
model, TEWL was increased in WT mice exposed to ASP
compared with saline (SAL)-treated mice. This was signifi-
cantly attenuated in the Serpinb3a KO mice treated with ASP
after both the second and third patches (Figure 2b and c). The
skin was visually evaluated, and skin scores were assigned on
the basis of redness, skin thickening, and excoriations. Skin
scores were increased following cutaneous ASP exposure in
WT mice but were markedly attenuated in Serpinb3a KO mice
(Figure 2d). Consistent with the TEWL and skin scores,
epidermal thickness was increased following cutaneous ASP
exposure in the WT mice but was only slightly elevated (close
to SAL treatment) in the Serpinb3a KO mice (Figure 2e).
Collectively, the data indicate that Serpinb3a contributes to
disruption of the skin barrier early in the response to allergen
exposure.
Attenuated early inflammation in the absence of Serpinb3a
Histological examination of hematoxylin and eosin-stained
skin sections revealed a significant increase in the influx of
inflammatory cells into the epidermis following cutaneous
ASP exposure in the WT mice (Figure 3a and c). This effect
was attenuated in the Serpinb3a KO mice (Figure 3b and d).
These findings were confirmed following staining for CD3 (T
cells; Figure 3e and f) and Ly6G (neutrophils; data not shown),
which revealed decreased influx of T cells and neutrophils
into the skin of Serpinb3a KO mice.
Total IgE levels were increased in both WT and Serpin3a
KO mice following cutaneous AF exposure, and there were no
significant differences between the two strains (Figure 3g).
ASP-specific IgG1 and -IgE levels were increased in the
Serpinb3a KO mice compared with wild-type mice, suggest-
ing that these mice may be more easily sensitized compared
with WT Balb/c mice (Figure 3h and i). Although statistically
significant, in each replicate, only one or two mice had
elevated allergen-specific antibody levels, making the biolo-
gical relevance of this observation questionable.
Correlation between TEWL and the pro-inflammatory S100A8
gene
The onset of acute AD lesions in humans is associated with
increased expression of the S100 family of proteins (specifi-
cally S100A7, A8, and A9) (Gittler et al., 2012). Studies have
shown that S100A9 expression is regulated in an S100A8-
dependent manner (Riva et al., 2013). Thus, we determined
the impact of Serpinb3a deficiency on S100A8 mRNA
expression. Consistent with our previously published data
(Brandt et al., 2013), S100A8 (Figure 4a) and Serpinb3a
(Figure 4b) mRNA levels were significantly induced in WT
mice following ASP exposure. In our shorter model, TEWL
correlated with S100A8 mRNA expression levels (r¼ 0.571,
P¼0.0185; Figure 4c). Induction of S100A8 was markedly
attenuated in the Serpinb3a KO mice (Figure 4a). S100A8
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Figure 2. Serpinb3a contributes to barrier dysfunction in early atopic
dermatitis (AD). (a) Schematic describing our early AD model. Transepidermal
water loss (TEWL) measurements after the second (b) and third (c) patches.
(d) Scoring of AD-like phenotypes (excoriations, redness, and thickening).
(e) Quantification of epidermal thickness after the third allergen patch. Data
shown are representative of three independent experiments (n¼ 6–8 per
group).
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Figure 3. Inflammation is attenuated in the absence of Serpinb3a.
Representative hematoxylin and eosin (H&E)-stained sections of patched skin
(magnification  20) from wild-type saline (WT-SAL) (a), knockout saline (KO-
SAL) (b), wild-type Aspergillus fumigatus extract (WT-ASP) (c), and knockout
Aspergillus fumigatus extract (KO-ASP) (d) mice. Representative CD3-stained
sections of patched skin from WT-ASP (e) and KO-ASP (f) mice. Sensitization to
allergen measured by total serum IgE levels (g), ASP-specific IgG1 (h), and ASP-
specific IgE (i). Data shown are representative of three independent
experiments. Scale bar¼ 100mm.
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Figure 4. Serpinb3a expression correlates with S100A8 expression in mouse
skin. Quantitative real-time PCR for S100A8 (a) and Serpinb3a (b) normalized
to HPRT for the indicated groups. Correlation plots between transepidermal
water loss (TEWL) and S100A8/HPRT (c) and between Serpinb3a/HPRT and
S100A8/HPRT (d). Expression of SERPINB4 (e) and S100A8 (f) in three
independent clones (clone 1–3) stably transfected with shRNA targeting
SERPINB3/B4 compared with a clone generated with the empty vector
(control), normalized to glyceraldehyde-3-phosphate dehydrogenase
(GAPDH). HPRT, hypoxanthine-guanine phosphoribosyltransferase.
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expression correlated with Serpinb3a levels (r¼0.7516,
P¼0.0008; Figure 4d) in wild-type mice, indicating that
Serpinb3a may impact S100A8 expression.
SERPINB3/B4 downregulation results in decreased S100A8
expression in human keratinocytes
To determine whether Serpinb3a directly impacted the expres-
sion of S100A8 in the epithelium versus an indirect effect on
expression due to fewer inflammatory cells in the skin, we
generated stable clones expressing shRNAs targeting SER-
PINB3/B4 in HaCaT cells, a human keratinocyte cell line,
and examined the effect on S100A8 expression. The shRNA
clones showed decreased SERPINB4 mRNA by over 90%
(Figure 4e). Depletion of SERPINB3/B4 alone was sufficient to
decrease S100A8 mRNA levels in three independent shRNA-
transduced stable cell lines (Figure 4f), supporting a role for
SERPINB3/B4 in the induction of the expression of S100A8.
SERPINB3/B4 expression correlates with S100A8 expression in
AD skin
To determine whether our observations demonstrating an
effect of SERPINB3/B4 on S100A8 expression in a mouse
model of skin inflammation were also evident in humans, we
examined published microarray data comparing normal skin
with lesional skin from subjects with AD (Guttman-Yassky
et al., 2009). When looking at probes specific for SERPINB3
and/or SERPINB4, SERPINB3 and SERPINB4 expression was
significantly increased in AD skin compared with normal skin
(Figure 5a–c). In addition, S100A8 expression was also signifi-
cantly upregulated in AD skin (Figure 5d). In all cases, there
was significant correlation between SERPINB3/B4 expression
and S100A8 levels in AD skin (Figure 5e–g). Together, these
data support a role for Serpinb3a in mice and SERPINB3/B4 in
humans in regulating the expression of S100A8.
RNA-seq analysis shows differential early expression of
pro-inflammatory genes between WT and Serpinb3a-null mice
On the basis of our observations, it is clear that Serpinb3a acts
early in response to cutaneous allergen exposure. To identify
very early changes caused by Serpinb3a, we used RNA-seq
followed by Ingenuity Pathways analysis (IPA) to study global
changes in gene expression in WT and Serpinb3a KO mice
following a single application of allergen. For both genotypes,
we identified genes whose expression was significantly induced
or repressed in the ASP-treated group compared with SAL
controls, filtered the lists to those with a 2.5-fold or greater
change (increase or decrease), and performed IPA indepen-
dently for the WT and KO mice. In the WT mice, the primary
network of genes regulated by ASP identified by IPA was
related to hematological system development and function,
tissue morphology, and cellular movement. This included
upregulation of the pro-inflammatory cytokines (IL-4, EBI3)
and chemokines (CXCL13, CCL24, and CCL25), downregulation
of an inhibitor of T-cell apoptosis (NR4A1), and differential
expression of regulators of development and differentiation
(CTLA2a, INHBB, CSDC2, and ALPNRe), and metabolism
(KHK, NR1H4) (Figure 6a). IPA also identified inflammation
and immune responses as the key processes affected in the
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Figure 5. Serpinb3a expression correlates with S100A8 expression in human
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SERPINB3/B4 and S100A8 (g).
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WT mice following allergen exposure. When we examined
the expression of the genes in this same network in the
Serpinb3a KO mice, only a small fraction were differentially
expressed (Table 1).
In contrast, the primary network identified by IPA in the
Serpinb3a KO mice included genes regulating cell morphol-
ogy, cellular assembly and organization, and cellular devel-
opment. They contained genes that regulate or are regulated by
mitogen-activated protein kinase (MAPK), PI3K, NF-kB, or AKT
signaling pathways (Figure 6b), all of which been implicated in
mediating allergic responses (Sharon et al., 2011; Choi et al.,
2013). These include genes that regulate T-cell survival and
signaling (TNFSF18, DAPP1), B-cell survival (TNFSF13C),
neutrophil infiltration and activation (TRPM2, IL-24), along
with a variety of genes involved in development (LAMA1,
GDNF, GCM1, EFNB1, THPO, TAS1R1, EFNA1, and CALR)
and cell cycle (CCNE1, NCAPD2). It is important to highlight
that expression of most of the pro-inflammatory genes is
downregulated in the absence of Serpinb3a. As the differences
in expression of signaling pathway proteins were observed after
a single patch of allergen, this observation, combined with the
increased expression of pro-inflammatory genes in the WT mice,
supports a role for Serpinb3a in early inflammatory responses in
the skin following allergen exposure.
DISCUSSION
In this study, using an approach that integrates mouse models
of AD and in vitro knockdown studies in human keratinocytes
with analysis of human disease expression data, we have
identified a role for the serine protease inhibitor Serpinb3a
following allergen exposure. Serpinb3a regulates expression of
the pro-inflammatory gene S100A8, with a significant impact
on barrier function as assessed by TEWL. Collectively, our
data reveal that human SERPINB3/B4 (Serpinb3a in mice)
contributes to the cutaneous inflammatory response during the
pathogenesis of more chronic skin diseases.
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Figure 6. Primary network of Aspergillus fumigatus extract (ASP)-affected
genes generated by Ingenuity Pathway analysis (IPA). A list of differentially
expressed genes (X2.5-fold up- or downregulated) when comparing ASP-
patched with saline (SAL)-patched mice was generated for wild-type (WT) mice
(a) and Serpinb3a knockout (KO) mice (b) separately. Each list of genes was
submitted independently subjected to IPA to identify the top networks affected
in the WT and Serpinb3a KO mice. Genes marked in red were upregulated,
whereas genes in blue were downregulated in the ASP-patched mice when
compared with SAL-patched mice.
Table 1. Ingenuity pathway analysis of differentially
expressed genes
Name P-value # in WT1 # in KO1
Diseases and disorders
Inflammatory response 6e 5–0.05 14 2
Gastrointestinal disease 0.001–0.05 7 1
Hematological disease 0.001–0.05 5 1
Immunological disease 0.001–0.05 10 1
Inflammatory disease 0.001–0.05 9 1
Physiological system development and function
Hematological system
development and function
6e 5–0.05 11 2
Humoral immune response 6e 5–0.04 3 2
Immune cell trafficking 6e 5–0.04 6 2
Cell-mediated immune response 6e 5–0.05 7 2
Organ morphology 0.001–0.05 10 1
Abbreviations: KO, knockout; WT, wild type.
1# In WT and # in KO refer to the number of genes in each category that
were differentially expressed in either the WT or KO mice following
Aspergillus fumigatus extract (ASP) challenge. P-values are for the sig-
nificance of association with the indicated disease/disorder in the WT
mice.
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In a mouse model of asthma, we have previously shown
that Serpinb3a KO mice have attenuated airway hyperrespon-
siveness and goblet cell hyperplasia. In this model, there was
very little impact of Serpinb3a on inflammation after 3 weeks
of exposure to dust mites. However, Serpinb3a-deficient mice
treated with IL-13 alone for 1 week showed attenuated
inflammation in addition to attenuated airway hyperrespon-
siveness and mucus production (Sivaprasad et al., 2011).
Similar to our current findings in the skin, these data suggest
that Serpinb3a promotes inflammation early in the
pathogenesis of allergic disease. With continued allergen
exposure, AD developed even in the absence of Serpinb3a,
indicating that other compensatory pathways are activated to
restore the full inflammatory response. This is further
supported by our RNA-seq data, which revealed that
expression of genes in several pro-inflammatory signaling
pathways induced early during allergic responses is
attenuated in the absence of Serpinb3a, consistent with
attenuated skin inflammation phenotype. SERPINB3/B4 has
been implicated in these pro-inflammatory responses
previously. Transfection of human epidermal keratinocytes
with SERPINB4 was sufficient to induce expression of IL-1
alpha (Titapiwatanakun et al., 2005), which is known to
induce expression of S100A8/A9 in a p38 mitogen-activated
protein kinase-dependent manner (Bando et al., 2013). Our
microarray data did not detect increased expression of S100A8
in the WT mice. This is likely because the time point chosen
for the RNA-seq (with a view to identifying very early changes
that drive the decreased expression of S100A8) was too short
to see any induction.
The role of IL-4 in regulating TEWL and barrier function has
been well established (Sehra et al., 2010; Brandt and
Sivaprasad, 2011). Our RNA-seq data in the WT mice also
suggest that the more robust increase in TEWL in the WT mice
is driven by an early increase in pro-TH2 responses.
Numerous studies have shown that SERPINB3/B4 protects
cells from apoptosis in response to various triggers (Suminami
et al., 2000; Murakami et al., 2001; Katagiri et al., 2006; de
Koning et al., 2011; Song et al., 2012). None of our studies,
either in vitro or in vivo, has identified an obvious impact on
apoptosis in the absence of Serpinb3a/SERPINB3/B4. One
explanation is that ASP extract may not induce similar
responses as DNA-damaging triggers (UV, gamma radiation)
or TNF-a. SERPINB3 has been shown to have a protective
effect in lysosomal injury–induced necrosis and an enhancing
effect on endoplasmic reticulum stress–induced apoptosis
(Ullman et al., 2011). How exactly these SERPINB3-
regulated processes contribute to the development and/or
persistence of AD remains to be evaluated.
Examination of the RNA-seq data for mechanistic explana-
tion provides few answers. IL-24 is known to increase skin
inflammation induced by TNF in the absence of NFkB activity
(Kumari et al., 2013). TRPM2 is a Ca2þ permeable cation
channel that is required for T-cell proliferation and pro-
inflammatory cytokine secretion as well as other phenotypes
in an experimental model of autoimmune encephalomyelitis.
It would be interesting to speculate that downregulation of one
or both of these molecules could explain the attenuated
inflammation in the absence of Serpinb3a. However, the
relevance of these findings remains to be established.
Serine proteases are important regulators of the balance
between basal cell proliferation and desquamation to form the
stratum corneum of the skin (Cork et al., 2009). One possible
role for Serpinb3a in the skin is to modulate the function of
one of the proteases involved in this process. Thus, it was
surprising to us that the deletion of a serine protease inhibitor
(implying increased serine protease activity in the skin) did not
result in an exacerbation of the disease phenotype. In our
studies, histological comparison of skin sections of WT and
Serpinb3a-null mice revealed no significant differences in
gross skin architecture; however, subtle differences in
epidermal structure cannot be excluded.
Recent genetic studies have identified single-nucleotide
polymorphisms (SNPs) in SERPINB3/B4. A SNP in SERPINB3
that increased the protease inhibitory function of the protein
was associated with liver cirrhosis (Turato et al., 2009).
Another study identified a functional SNP in the SERPINB3
promoter associated with skin prick test positivity in asthmatic
children that impacted binding of the transcription factors
GATA2 and GATA3 after IL-4 and IL-13 treatment (Karaaslan
et al., 2013). The impact of increased expression or activity of
a protease inhibitor resulting in worse disease would suggest
that the serine protease targeted by SERPINB3 would serve an
anti-inflammatory role in the skin. This hypothesis is consistent
with our finding of attenuated inflammation in the skin
following depletion of Serpinb3a. Studies in our laboratory
are currently ongoing to determine the association of SNPs in
the SERPINB3/B4 locus with AD.
Current treatments for AD are focused mostly on skin
hydration and topical corticosteroids. Better understanding of
the molecular basis for skin inflammation will facilitate new
drug development (Schakel et al., 2014). Our studies have
identified one such pathway, driven by SERPINB3/B4. It is
tempting to speculate that early intervention with treatment
that attenuates SERPINB3/B4 expression or activity may be
beneficial for primary prevention, attenuation, or delayed onset
of chronic skin diseases like AD. This pathway might also serve
as an important predictor of the natural history of AD.
Alternatively, studies could examine the contribution of this
pathway to sensitivity to the number and/or type of AD triggers.
MATERIALS AND METHODS
Mice
Serpinb3a-null mice (Sivaprasad et al., 2011) and BALB/c mice
(Harlan Laboratories, Indianapolis, IN) were kept in a pathogen-free
environment. All procedures were performed in accordance with the
ethical guidelines in the Guide for the Care and Use of Laboratory
Animals of the Institutional Animal Care and Use Committee
approved by the Veterinary Services Department of the Cincinnati
Children’s Hospital Medical Center.
Epicutaneous antigen sensitization and challenge
The conventional cutaneous inflammation protocol has been pre-
viously described (Sivaprasad et al., 2010). Briefly, for both models
(summarized in Figure 1a and 2a, respectively), the mice were shaved
and 24 hours later epicutaneously treated with 200mg of ASP extract
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(Greer Laboratories, Lenior, NC) in 200ml of sterile SAL or SAL alone
as control. The allergen was applied to a 2-cm2 gauze patch and
taped to the back of the mice with tagaderm, a band aid, and water-
resistant tape. For the long model, the patch was removed on day 6,
and 24 hours later a new patch reapplied, and repeated one more
time, for a total of three patches. For the short protocol, the patch was
removed on day 3, and the patch reapplied 24 hours later, and repeated
one more time, for a total of three patches. TEWL was measured
24 hours after the second and third patches. At 24 hours after the last
patch, the mice were killed following standard procedures.
Measurement of TEWL
TEWL was measured by using the Dermalab instrument DermaLab
USB module (Cortex Technology, Hadsund, Denmark), as previously
described (Sivaprasad et al., 2010). An average of the two readings
was used for each mouse, and all measurements were made by the
same investigator.
Skin scoring system
Mice were visually assessed for excoriations, erythema, and skin
thickening in the 2-cm2 area covered by the patch as previously
described (Sivaprasad et al., 2010).
Tissue processing and measurement of epidermal thickness
Skin tissues were fixed in 10% formalin, cut into 5mm sections, and
stained with hematoxylin and eosin as per the manufacturer’s
protocol. Epidermal thickness was measured by first capturing eight
images per section at  100 magnification with a Nikon (Melville,
NY) 80i microscope, and then taking eight measurements per image
using the Nikon Elements software program. Data are plotted as the
average of the 64 measurements per section for each mouse. CD3
staining was performed by the Pathology Core at Cincinnati Chil-
dren’s Hospital Medical Center.
ELISAs
Plasma was diluted 1:10 for ASP-specific IgE and IgG1, 1:500 for total
IgE, and 1:2 for IL-4 and IL-17. ELISAs were performed using the
appropriate kit from BD Biosciences (San Jose, CA) (IgG1 and IgE) or
Biolegend (San Diego, CA) (IL-4 and IL-17A). For ASP-specific IgE and
IgG1, wells were coated with 0.01% ASP extract, and the rest of the
protocol was carried out as recommended in the kits.
Generation of stable shRNA clones
SERPINB4 shRNA lentiviral clones TRCN52408 and TRCN52409 of
the MISSION shRNA library (Sigma Aldrich, St Louis, MO) were
purchased from the Lenti-shRNA Library Core at Cincinnati Children’s
Hospital Medical Center. HaCaT cells (kindly provided by Dr T.
Bowden, University of Arizona, Tuscon, AZ) were transduced using
standard methods (Woods et al., 2009). Seventy-two hours post
transduction, the cells were exposed to puromycin 5mg ml 1
(Sigma Aldrich). Cells that continued to grow in puromycin-
containing medium were passaged to generate clonal cell popula-
tions by serial dilution. Once confluent, cells were harvested, and RNA
was isolated as described below.
Reverse transcriptase–PCR
Total RNA was isolated from cells using Trizol (Invitrogen, Carlsbad,
CA) according to the manufacturer’s instructions and DNase treated
(Qiagen, Valencia, CA) before being reverse transcribed with the First
Strand Superscript Synthesis kit (Invitrogen). Quantitative PCR
analysis was performed using the following primers: (1)
mouse hypoxanthine-guanine phosphoribosyltransferase: forward
50-TGCCGAGGATTTGGAAAAAG-30, reverse 50-CCCCCCTTGAGCA
CACAG-30; (2) mouse S100A8: forward 50-CCATGCCCTCTACAAGA
ATG-30, reverse 50-ATCACCATCGCAAGGAACTC-30; (3) mouse Ser-
pinb3a: forward 50-CAGATGATGAAACAAAACATCG-30, reverse 50-A
GACCTTGAGTGCTGCTCATA-30; (4) human GAPDH: forward 50-G
GGGAAGGTGA;AGGTCGGAGTCA-30, reverse 50-AGCCTTGACGG
TGCCATGGAAT-30; (5) human S100A8: forward 50-ATGTTGACCGA
GCTGGAGAAAG-30, reverse 50-TTCAGGTCATCCCTGTAGACG
G-30; and (6) human SERPINB4: forward 50-GTCGATTTACACTTAC
CTCGG-30, reverse 50-GCCTTGTGTAGGACTTTAGATACT-30.
Human expression data
Human expression data from Guttman-Yassky et al. (2009)
(GSE16161) were imported into GeneSpring GX software (Agilent
Technologies, Santa Clara, CA), and the intensities for each chip were
normalized relative to the median of the control samples.
RNA-Seq expression analysis
RNA was extracted from mouse skin using the Trizol reagent. A total
of 2.5mg RNA from three mice from each treatment group (WT-SAL,
WT-ASP, KO-SAL, and KO-ASP) was used for RNA-seq analysis. RNA-
seq was performed by Genomics Sequencing Core in the University of
Cincinnati. The RNA-seq library was constructed using the PrepX SPIA
RNA-Seq kit (IntegenX, Pleasanton, CA) and Apollo 324 NGS Library
Prep System (IntegenX, WaferGen Biosystems, Fremont, CA), and
10 ng of total RNA was converted into cDNA suitable for mRNA
sequencing. The cDNA was then sheared by Covaris S2 (Covaris,
Woburn, MA) under the condition recommended by IntegenX,
followed by assay of the size distribution with the Agilent High
Sensitivity DNA kit (Agilent, Santa Clara, CA). The properly sheared
cDNA fragments were purified by Agencourt AMPure XP meganetic
beads (Beckman Coulter, Brea CA). Using the IntegenX PrepX ILM
DNA library kit and the Apollo 324 NGS Library Prep System, 500 ng
of purified cDNA fragments were then subjected to end repair and
addition of a single ‘A’ base, ligation of adapters, and indexed
individually. The products were purified and enriched by PCR to
create the final cDNA library targeting mRNAs. The size of the
generated library was validated by Bioanalyzer, and the library was
quantified using the Kapa Library Quantification kit (Kapabiosystem,
Woburn, MA). Twelve individually indexed cDNA libraries of equal
amount were pooled for clustering in the cBot system (Illumina, San
Diego, CA). Libraries at the concentration of 6.5 pM were clustered
onto a flow cell using Illumina’s TruSeq SR Cluster Kit v3 and
sequenced for 50 cycles using the TruSeq SBS kit on the Illumina
HiSeq system.
Sequence reads were aligned to the reference mouse genome
(mm10) using TopHat aligner (Trapnell et al., 2009). The counts of
reads aligning to each gene’s coding region were summarized using
ShortRead (Morgan et al., 2009) Bioconductor package and custom-
written R programs (Ihaka and Gentleman, 1996). Statistical analysis
to identify genes differentially expressed between ASP- and SAL-
treated WT and KO mice was performed using the negative-binomial
model of read counts as implemented in the DESeq Biocondoctor
package (Anders and Huber, 2010). Transcripts with 2.5-fold change
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and P-value o0.05 were considered differentially expressed and
were further analyzed by IPA. The GEO accession number is
GSE54640.
IPA analysis
Data were analyzed using QIAGEN’s Ingenuity Pathway Analysis
(IPA, QIAGEN Redwood City, www.qiagen.com/ingenuity). The
biological functions and/or diseases that were most significant were
identified, using the list of differentially regulated genes and the
Ingenuity Pathways Knowledge Base. Fisher’s exact test was used to
calculate a P-value determining the probability that each biological
function and/or disease assigned to the list is due to chance alone.
The list of 53 genes was overlaid onto a global molecular network
developed from information contained in the Ingenuity Pathways
Knowledge Base, and networks were then algorithmically generated
on the basis of connectivity.
Statistical analysis
Reported values are expressed as mean±SD. All experiments were
conducted with at least 6–8 mice per group. Each dot on the graphs
represents an independent mouse. Data shown are representative of
three independent replicates. All statistical analyses were performed
using PRISM software (GraphPad Software, La Jolla, CA). For all
studies, statistical significance was assessed using one-way analysis of
variance followed by a Tukey–Kramer post-test (for statistical sig-
nificance between groups). Significance was set at a P-value of 0.05.
Correlation analysis was performed using a Spearman correlation test.
For the human expression data, statistical significance was deter-
mined using the Mann–Whitney test.
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